학술논문
Serum glial fibrillary acidic protein (GFAP) is a longitudinal indicator of disease progression in MS while neurofilament light chain (NfL) associates with therapy response in patients under B-cell depleting therapy
Document Type
ConferencePaper
Author
Benkert, P; Maceski, AM; Schadelin, S; Willemse, E; Meier, S; Melie-Garcia, L; Cagol, A; Galbusera, R; Subramaniam, S; Lorscheider, J; Fischer-Barnicol, B; Achtnichts, L; Findling, O; Lalive, P; Bridel, C; Muller, S; Pot, C; Mathias, A; Du Pasquier, R; Salmen, A; Hoepner, R; Chan, A; Disanto, G; Zecca, C; Orleth, A; DSouza, M; Yaldizli, O; Derfuss, T; Oechtering, J; Gobbi, C; Khalil, M; Abdelhak, A; Oksenberg, JR; Hermesdorf, M; Berger, K; Wiendl, H; Piehl, F; Conen, D; Buser, A; Kappos, L; Granziera, C; Leppert, D; Kuhle, J
Source
MULTIPLE SCLEROSIS JOURNAL. 29:58-60
Subject
Language
English
English
English
ISSN
1352-4585